Alkem Laboratories
- Advice
- Hold
Alkem Laboratories Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Alkem Laboratories
Start SIPAlkem Laboratories Investment Rating
-
Master Rating:
-
Alkem Laboratories has an operating revenue of Rs. 11,180.52 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 17% is great, ROE of 19% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 5% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 2% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 62 which is a FAIR score but needs to improve its earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 2,297 | 2,461 | 2,058 | 2,006 |
| Operating Expenses Qtr Cr | 1,841 | 2,056 | 1,875 | 1,807 |
| Operating Profit Qtr Cr | 456 | 406 | 183 | 200 |
| Depreciation Qtr Cr | 58 | 58 | 57 | 55 |
| Interest Qtr Cr | 23 | 20 | 22 | 13 |
| Tax Qtr Cr | 47 | 51 | 20 | 109 |
| Net Profit Qtr Cr | 389 | 351 | 140 | 77 |
Alkem Laboratories Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- 3178.62
- 50 Day
- 3155.93
- 100 Day
- 3140.74
- 200 Day
- 3155.36
- 20 Day
- 3151.63
- 50 Day
- 3150.79
- 100 Day
- 3117.36
- 200 Day
- 3118.11
Alkem Laboratories Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 3266.6 |
| Second Resistance | 3292.4 |
| Third Resistance | 3324.9 |
| RSI | 63.73 |
| MFI | 62.3 |
| MACD Single Line | 1.44 |
| MACD | 17.58 |
| Support | |
|---|---|
| First Resistance | 3208.3 |
| Second Resistance | 3175.8 |
| Third Resistance | 3150 |
Alkem Laboratories Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 75,885 | 3,075,619 | 40.53 |
| Week | 101,884 | 4,743,700 | 46.56 |
| 1 Month | 74,947 | 3,716,612 | 49.59 |
| 6 Month | 85,048 | 4,187,754 | 49.24 |
Alkem Laboratories Result Highlights
Alkem Laboratories Synopsis
NSE-Medical-Diversified
Alkem Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 8829.81 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2022. Alkem Laboratories Ltd. is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201.| Market Cap | 39,460 |
| Sales | 8,823 |
| Shares in Float | 5.14 |
| No of funds | 203 |
| Yield | 0.58 |
| Book Value | 4.51 |
| U/D Vol ratio | 2.1 |
| LTDebt / Equity | |
| Alpha | -0.04 |
| Beta | 0.35 |
Alkem Laboratories
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 57.16% | 57.16% | 57.14% | |
| Mutual Funds | 10.06% | 9.42% | 7.85% | |
| Insurance Companies | 5.87% | 5.84% | 6.03% | |
| Foreign Portfolio Investors | 4.41% | 4.46% | 5.67% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 21.73% | 22.28% | 22.33% | |
| Others | 0.77% | 0.84% | 0.98% |
Alkem Laboratories Management
| Name | Designation |
|---|---|
| Mr. Basudeo N Singh | Executive Chairman |
| Mr. Sandeep Singh | Managing Director |
| Mrs. Madhurima Singh | Executive Director |
| Mr. Balmiki Prasad Singh | Executive Director |
| Mr. Mritunjay Kumar Singh | Executive Director |
| Mr. Sarvesh Singh | Executive Director |
| Mr. Arun Kumar Purwar | Independent Director |
| Ms. Sangeeta Singh | Independent Director |
| Ms. Sudha Ravi | Independent Director |
| Dr. Dheeraj Sharma | Independent Director |
| Mr. Narendra Kumar Aneja | Independent Director |
| Mr. Sujjain Suresh Talwar | Independent Director |
Alkem Laboratories Forecast
Price Estimates
Alkem Laboratories FAQs
What is Share Price of Alkem Laboratories ?
Alkem Laboratories share price is ₹3300 As on 30 March, 2023 | 17:19
What is the Market Cap of Alkem Laboratories ?
The Market Cap of Alkem Laboratories is ₹39460 Cr As on 30 March, 2023 | 17:19
What is the P/E ratio of Alkem Laboratories ?
The P/E ratio of Alkem Laboratories is 38.7 As on 30 March, 2023 | 17:19
What is the PB ratio of Alkem Laboratories ?
The PB ratio of Alkem Laboratories is 4.5 As on 30 March, 2023 | 17:19